30.04.2021 23:00:00

World In-Vitro Fertilization (IVF) Market Report 2021, Featuring Boston IVF, Care Fertility, Cook Medical, GE Healthcare and Vitrolife AB

Dublin, April 30, 2021 /PRNewswire/ -- The "Global In-Vitro Fertilization Market 2020-2030: Focus on Products, Types, Procedures, End-users, Country Data (16 Countries), and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.

The global in-vitro fertilization market is projected to reach $51.51 billion by 2030. The study highlights that the market is set to witness a CAGR of 9.37% during the period 2020-2030.

Infertility is a serious health issue worldwide, affecting approximately 8%-10% of couples worldwide. According to CDC, 2013 and Office on Women's Health, 2019 reports, about 9% of men and 10% of women aged 15 to 44 reported infertility problems in the U.S., and according to the Reproductive Biological Endocrinology, 2015 report, around 48.5 million couples experience infertility, globally. In response to these issues, countries across the globe are striving hard to increase their fertility rates, thereby promoting high adoption of assisted reproductive technologies (ART). ART are cutting-edge technologies that help to treat infertility by manipulating sperm and/or eggs outside the human body.

The global in-vitro fertilization market consists of systems, media, and reagents, and pharmaceuticals used to carry out the entire procedure, from monitoring and stimulating a woman's ovulatory process to the final implantation of the embryo into the concerned woman's fallopian tube to bringing out a successful pregnancy. The increasing incidence of infertility owing to lifestyle changes, such as an increase in the median age of first-time motherhood, is a major factor contributing to the growth of the global in-vitro fertilization market.

Healthcare experts have found in-vitro fertilization to be one of the most rapidly evolving techniques, and the global market for in-vitro fertilization is predicted to grow at a CAGR of 9.37% over the forecast period 2020-2030. An increase in the trend of delayed pregnancies, changing lifestyles in urban areas, and increased age of parenthood bolster the growth of the global IVF market. The following report presents the reader with an opportunity to unlock comprehensive insights with respect to the global IVF market and helps in forming well-informed strategic decisions. The market research study also offers a wide perspective of the different types of products and services available in the market and their impact on the healthcare sector by providing critical insights into the direction of its future expansion.

Declining fertility rates, changing lifestyles in urban areas, and increased age of parenthood are expected to be the primary factors driving the growth of the global IVF market. Government funding encouraging infertility treatments in addition to the industrial revolutions and technological advancements in the ART field is further expected to accelerate the growth of the market during the forecast period 2020-2030.

Study scope:

  • Market numbers on micro-segments that are influencing the market
  • More than 1000 products present in the market
  • Pricing data for products and procedures
  • Over 250 brands were evaluated
  • Market share analysis for more than 20 product categories
  • End-user preference data for over 50 end users
  • Detailed global and regional market share analysis, including the scrutiny of more than 16 countries
  • Data study of more than 25 companies

Company Profiles

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Boston IVF
  • Care Fertility
  • Cook Medical
  • Esco Group of Companies
  • F. Hoffmann-La Roche Ltd.
  • FUJIFILM Irvine Scientific
  • GE Healthcare
  • Genea Limited
  • Illumina, Inc.
  • Invitae Corporation
  • IVFtech ApS
  • Kaiser Permanente
  • Kitazato Corporation
  • Laboratory Corporation of America Holdings (Labcorp)
  • Merck KGaA
  • Monash IVF Group
  • Natera, Inc.
  • Progyny, Inc.
  • The Cooper Companies Inc.
  • Thermo Fisher Scientific, Inc.
  • Vitrolife AB

For more information about this report visit https://www.researchandmarkets.com/r/ovm60a

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/world-in-vitro-fertilization-ivf-market-report-2021-featuring-boston-ivf-care-fertility-cook-medical-ge-healthcare-and-vitrolife-ab-301281221.html

SOURCE Research and Markets

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!